American Journal of Infection Control

The prevalence of multidrug-resistant organisms (MDROs) in the inpatient setting continues to increase due to gaps in infection control practices that facilitate their transmission. Although the isolation of hospitalized patients is effective at

Laboratory-identified (LabID) cases of Clostridrioides difficile infection (CDI) are a publicly reported metric to the National Healthcare Safety Network (NHSN). Diagnosing CDI by polymerase chain reaction (PCR) does not allow for identification of C

Patients with end-stage renal disease (ESRD) are at increased risk for Hepatitis B virus (HBV) exposure and subsequent infection. Waning immunity, despite strong initial vaccination efforts, is increasingly common and leads to serial testing and

In Japan, the new coronavirus disease 2019 (COVID-19) vaccination began in April 2021 for local residents. Many patients who wish to be vaccinated have voiced concerns about side effects. Our cardiovascular hospital with fewer than 100 beds has

Precautions to prevent the spread of coronavirus infectious disease 2019 (COVID-19) were designed to limit contact between individuals and to control the spread of infectious organisms, yet these prevention measures present an obstacle for patients

An academic medical center was experiencing increased incidences of central line associated blood stream infections (CLABSI). Traditional line lists were proving ineffective in identifying root causes. In an effort to better understand data, and to

Candida auris (C. auris) is a drug-resistant fungus that can spread easily between hospitalized patients and nursing home residents. To mitigate risk of C. auris spread, a nine-hospital healthcare system developed a C. auris screening tool in January

Methicillin-resistant Staphylococcus aureus (MRSA) infections are a source of morbidity and mortality for hospitalized patients. While a universal MRSA decolonization approach is considered more effective than active surveillance and decolonization

Contaminated surfaces in patient care areas contribute to the transmission of multidrug resistant organisms (MDROs) and increase the risk of infection in patients. Our current process did not include an objective validation measure for how thoroughly

Our academic medical center currently has three job roles within the infection preventionist (IP) job category: IP associate, IP, and senior IP. There is no clear guidance or checklist for progressing through the job roles or criteria for promotion